uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.
Uppsala University, Humanistisk-samhällsvetenskapliga vetenskapsområdet, Faculty of Social Sciences, Department of Psychology.
Show others and affiliations
2005 (English)In: Biol Psychiatry, ISSN 0006-3223, Vol. 58, no 2, 132-42 p.Article in journal (Other scientific) Published
Abstract [en]

BACKGROUND: Evidence is accumulating that pharmacological blockade of the substance P preferring neurokinin-1 (NK1) receptor reduces anxiety. This study compared the effects of an NK1 receptor antagonist, citalopram, and placebo on brain activity and anxiety symptoms in social phobia. METHODS: Thirty-six patients diagnosed with social phobia were treated for 6 weeks with the NK1 antagonist GR205171 (5 mg), citalopram (40 mg), or matching placebo under randomized double-blind conditions. GR205171 was administered for 4 weeks preceded by 2 weeks of placebo. Before and after treatment, regional cerebral blood flow (rCBF) during a stressful public speaking task was assessed using oxygen-15 positron emission tomography. Response rate was determined by the Clinical Global Impression Improvement Scale. RESULTS: Patients improved to a larger extent with the NK1 antagonist (41.7% responders) and citalopram (50% responders), compared with placebo (8.3% responders). Within- and between-group comparisons showed that symptom improvement was paralleled by a significantly reduced rCBF response to public speaking in the rhinal cortex, amygdala, and parahippocampal-hippocampal regions. The rCBF pattern was corroborated in follow-up analyses of responders and subjects showing large state anxiety reduction. CONCLUSIONS: Short-term administration of GR205171 and citalopram alleviated social anxiety. Neurokinin-1 antagonists may act like serotonin reuptake inhibitors by attenuating neural activity in a medial temporal lobe network.

Place, publisher, year, edition, pages
2005. Vol. 58, no 2, 132-42 p.
Keyword [en]
Adult, Anxiety/*drug therapy/physiopathology, Cerebrovascular Circulation/*drug effects, Citalopram/*pharmacology/therapeutic use, Comparative Study, Double-Blind Method, Female, Humans, Male, Phobic Disorders/*drug therapy/physiopathology, Piperidines/*pharmacology/therapeutic use, Positron-Emission Tomography, Receptors; Neurokinin-1/antagonists & inhibitors, Research Support; Non-U.S. Gov't, Serotonin Uptake Inhibitors/*pharmacology/therapeutic use, Temporal Lobe/blood supply/radionuclide imaging, Tetrazoles/*pharmacology/therapeutic use
URN: urn:nbn:se:uu:diva-19636PubMedID: 16038684OAI: oai:DiVA.org:uu-19636DiVA: diva2:47408
Available from: 2006-11-30 Created: 2006-11-30 Last updated: 2011-01-12

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Furmark, TomasÅhs, FredrikFredrikson, Mats
By organisation
Department of Psychology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 205 hits
ReferencesLink to record
Permanent link

Direct link